GSK To Publicize Clinical Trial Data Of All Cleared Drugs
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline will be the first to start publicizing clinical trial data of all of its drugs (approved and failed) next year while protecting subjects’ personal privacy, CEO Andrew Witty announced.